Multiple immune and stromal cell populations via paracrine factors and cell-cell contact

This entry does not describe a single molecular target but rather a complex biological system known as the tumor microenvironment (TME) or tissue niche. It involves the intricate interplay between various immune cell populations (such as T cells, macrophages, and dendritic cells) and stromal components (such as cancer-associated fibroblasts and endothelial cells) (Hanahan & Coussens, 2012, Cancer Cell). Communication within this system is mediated through paracrine factors, including cytokines, chemokines, and growth factors, as well as direct cell-cell contact via surface receptors and ligands like PD-1/PD-L1 or Notch signaling (Balkwill et al., 2012, J Cell Sci). In disease states like cancer, this crosstalk is often hijacked to create an immunosuppressive environment that promotes tumor growth, angiogenesis, and metastasis (Arneth, 2019, Medicina). While therapeutic agents do not target this entire descriptive phrase, many modern drugs are designed to intervene at specific nodes within this network to reprogram the microenvironment. For example, checkpoint inhibitors disrupt inhibitory cell-cell contacts, while anti-angiogenic therapies target paracrine signaling to normalize the vasculature. Understanding these multi-cellular dynamics is critical for the development of combination therapies that address the complexity of the TME rather than focusing on a single cell type.

Other names

Tumor microenvironment (TME)Immune-stromal crosstalkCell-cell communicationParacrine signaling networkTissue microenvironment

Modulation of cellular interactions and signaling pathways within the tissue or tumor microenvironment to restore immune surveillance or inhibit pathological remodeling.